Fulgent Genetics (FLGT) Return on Capital Employed (2016 - 2026)

Fulgent Genetics has disclosed Return on Capital Employed across 11 years of filings, most recently posting 6.41% for Q1 2026.

• Return on Capital Employed for Q1 2026 came in at 6.41%, down 14.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 6.41% (down 14.0% YoY), and the FY2025 annual result was 1.3%, up 510.0% from the prior year.
• Return on Capital Employed came in at 6.41% for Q1 2026 at Fulgent Genetics, down from 4.9% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 49.65% in Q1 2022 to a low of 18.02% in Q3 2024.
• The 5-year median for Return on Capital Employed is 6.26% (2025), against an average of 2.16%.
• Across the five-year window, Return on Capital Employed sank 5132 bps in 2023 and jumped 1177 bps in 2025, its largest moves.
• Fulgent Genetics' Return on Capital Employed stood at 32.64% in 2022, then plunged by 149 bps to 15.98% in 2023, then surged by 60 bps to 6.41% in 2024, then increased by 23 bps to 4.9% in 2025, then plunged by 31 bps to 6.41% in 2026.
• The last three Return on Capital Employed figures came in at 6.41% (Q1 2026), 4.9% (Q4 2025), and 6.26% (Q3 2025), per Business Quant data.